Dose-dependent transduction of vesicular stomatitis virus G protein- pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts

Virology

Volumn 260, Issue 1, 1999, Pages 109-115

  Arai, Tohru ^a,b   Takada, Mizuho ^a   Ui, Motoyasu ^a   Iba, Hideo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b EISAI CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; GENE TRANSFER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION; VIRUS GENE;

EID: 0033587635     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9773     Document Type: Article

References (22)

1. Arai T., Matsumoto K., Saitoh K., Ui M., Ito T., Murakami M., Kanegae Y., Saito I., Cosset F. L., Takeuchi Y., Iba H. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines. J. Virol. 72:1998;1115-1121.
2. Batra R. K., Olsen J. C., Hoganson D. K., Caterson B., Boucher R. C. Retroviral gene transfer is inhibited by chondroitin sulfate proteoglycans/glycosaminoglycans in malignant pleural effusions. J. Biol. Chem. 272:1997;11736-11743.
3. Bowles N. E., Eisensmith R. C., Mohuiddin R., Pyron M., Woo S. L. C. A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo. Hum. Gene. Ther. 7:1996;1735-1742.
4. Burns J. C., Friedmann T., Driever W., Burrascano M., Yee J. K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA. 90:1993;8033-8037.
5. Chen S. T., Iida A., Guo L., Friedmann T., Yee J. K. Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system. Proc. Natl. Acad. Sci. USA. 93:1996;10057-10062.
6. Cosset F. L., Takeuchi Y., Battini J. L., Weiss R. A., Collins M. K. L. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:1995;7430-7436.
7. Doux J. M. L., Morgan J. R., Snow R. G., Yarmush M. L. Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J. Virol. 70:1996;6468-6473.
8. Dranoff G., Jaffee E., Lazenby A., Golumbek P., Levitsky H., Brose K., Jackson V., Hamada H., Pardoll D., Mulligan R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90:1993;3539-3543.
9. Kanegae Y., Lee G., Sato Y., Tanaka M., Nakai M., Sakaki T., Sugano S., Saito I. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nuclei Acids Res. 23:1995;3816-3821.
10. Kanegae Y., Takamori K., Sato Y., Lee G., Nakai M., Saito I. Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene. 181:1996;207-212.
11. Kavanaugh M. P., Miller D. G., Zhang W., Law W., Kozak S. L., Kabat D., Miller A. D. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA. 91:1994;7071-7075.
12. Luria S. E., Darnell J. E., Baltimore D., Campbell A. General Virology. 1978;Wiley, New York. p. 22-32.
13. Mastromarino P., Conti C., Goldoni P., Hauttecoeur B., Orsi N. Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. J. Gen. Virol. 68:1987;2359-2369.
14. Matsubara T., Beeman R. W., Shike H., Besansky N. J., Mukabayire O., Higgs S., James A. A., Burns J. C. Pantropic retroviral vectors integrate and express in cells of the malaria mosquito, Anopheles gambiae. Proc. Natl. Acad. Sci. USA. 93:1996;6181-6185.
15. Morgan J. R., LeDoux J. M., Snow R. G., Tompkins R. G., Yarmush M. L. Retrovirus infection: Effect of time and target cell number. J. Virol. 69:1995;6994-7000.
16. Naviaux R. K., Costanzi E., Haas M., Verma I. M. The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70:1996;5701-5705.
17. Ory D. S., Neugeboren B. A., Mulligan R. C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA. 93:1996;11400-11406.
18. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
19. Schlegel R., Tralka T. S., Willingham M. C., Pastan I. Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site. Cell. 32:1983;639-646.
20. Sharma S., Cantwell M., Kipps T. J., Friedmann T. Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector. Proc. Natl. Acad. Sci. USA. 93:1996;11842-11847.
21. Yang Y., Vanin E. F., Whitt M. A., Fornerod M., Zwart R., Schneiderman R. D., Grosveld G., Nienhuis A. W. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum. Gene Ther. 6:1995;1203-1213.
22. Yee J. K., Miyanohara A., LaPorte P., Bouic K., Burns J. C., Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA. 91:1994;9564-9568.